Sava Technologies raises $36.0M Series B (United Kingdom, Oct 2026)
Reach the investors backing rounds like this
Backed by Ascensia, Balderton Capital +4 more · verified emails and LinkedIn on Datapile
London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe - EU-Startups
Sava Technologies is a London-based HealthTech company developing a wearable biosensor platform that detects molecules beneath the skin. They have raised €32.08 million in a Series B round to fund manufacturing scale-up and commercial readiness. The company has also partnered with Ascensia for commercialization and distribution in Europe.
London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe EU-Startups
| Oct 08, 2026 | IMMIX | $3.5M | — | United Kingdom |
| Oct 03, 2026 | Extend Robotics | $3.3M | Seed | United Kingdom |
| Oct 01, 2026 | Metaview | $60.0M | Series C | United Kingdom |
| Sep 25, 2026 | StandardX | $12.7M | Seed | United Kingdom |
14,750 investors back startups in United Kingdom
You just read who funded Sava Technologies. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.